Charles River Laboratories International Inc. presented at the Evercore 8th Annual Healthcare Conference on December 3, 2025. During the event, company management discussed fourth-quarter demand trends, with a focus on improvements in Discovery and Safety Assessment (DSA) booking activity and related key performance indicators. The company highlighted continued positive momentum and upward trends in DSA net book-to-bill since the third fiscal quarter of 2025, while noting that typical holiday seasonality may impact near-term proposal and booking activity.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charles River Laboratories International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-054902), on December 03, 2025, and is solely responsible for the information contained therein.